Corporate Banner
Satellite Banner
ADME Tox
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Andy Richards receives BIA Lifetime Achievement Award

Published: Wednesday, February 13, 2013
Last Updated: Wednesday, February 13, 2013
Bookmark and Share
BBSRC Council member and life sciences entrepreneur Dr Andy Richards has received the BioIndustry Association (BIA) Lifetime Achievement Award.

He said: "It is truly gratifying to be honoured by the BIA in this way, and I would like to thank all of those who have worked with me. The UK life-science ecosystem is a tremendous community with the profound capacity to do real good. It punches well above its weight in global impact and has many more successes than are recognised and reported. As we enter the age of biology and personalised medicine it is a great place to be with great people."

As well as sitting on the BBSRC Council and BBSRC Audit Board, Dr Richards is a founder, active investor and director of more than 20 innovative healthcare and life-science companies over the last 12 years.

Tim Edwards, BIA Chairman, said: "Andy Richards is an enthusiast for and champion of UK bioscience. He has established numerous companies that are getting new medicines from an idea to approved products that help patients. He is a true leader in our sector who has continued to put his own money where his mouth is. Finally, and quite possibly most importantly, Andy spends time inspiring school and university students to be entrepreneurial and to consider following a career in an innovative sector, such as life sciences."


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,000+ scientific posters on ePosters
  • More than 4,400+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Breaking up the Superbugs’ Party
The fight against antibiotic-resistant superbugs has taken a step forward thanks to a new discovery by scientists.
Friday, August 16, 2013
Scientific News
Cell Transplant Treats Parkinson’s in Mice
A University of Wisconsin—Madison neuroscientist has inserted a genetic switch into nerve cells so a patient can alter their activity by taking designer drugs that would not affect any other cell.
Understanding Female HIV Transmission
Glowing virus maps points of entry through entire female reproductive tract for first time.
Experimental Drug Cancels Effect from Key Intellectual Disability Gene
A University of Wisconsin—Madison researcher who studies the most common genetic intellectual disability has used an experimental drug to reverse — in mice — damage from the mutation that causes the syndrome.
Common Class of Cancer Drugs May Not Lead to Cognitive Decline
UCLA study refutes 2015 research suggesting anthracyclines could cause memory loss, other impairments.
Designing Better Drugs
A rational drug engineering approach could breathe new life into drug development.
Genetic Approach May Lead to New Treatments for Digestive Diseases
Researchers at UMass Medical School have identified a new molecular pathway critical for maintaining the smooth muscle tone that allows the passage of materials through the digestive system.
Potential Target for Revolutionary Antibiotics
An international team of including the Lomonosov Moscow State University researchers discovered which enzyme enables Escherichia coli bacterium (E. coli) to breathe.
Unique Model for Studying ALS
Unique mouse model will allow researchers to better study the genetic origins and potential treatments of ALS.
Factors Influencing Influenza Vaccine Effectiveness Uncovered
The long-held approach to predicting seasonal influenza vaccine effectiveness may need to be revisited, new research suggests.
New Model to Enhance Zika Virus Research
The model will allow researchers to better understand how the virus causes disease and aid in the development of antiviral compounds and vaccines.
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,400+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!